From the day we founded Aesica in 2004, we have been committed to being fast, flexible, innovative and reliable. Qualities which are helping to make us one of the world’s leading contract developers and manufacturers of pharmaceuticals. Equally important to our growing success, but much harder to quantify, is our dedication to service and working in partnership to achieve outstanding results. We are constantly developing the technical and analytical skills of our people to ensure that we are capable of meeting the ever-changing demands of our customers. Our state-of-the-art facilities enable delivery of a full API development and manufacturing, formulation development and formulated products manufacturing services in a growing number of markets. Most importantly, we are aware that customers want more than a supplier, which is why we work in partnership to provide a flexible, efficient and dependable service. Our Vision Aesica’s vision is to become the number one supplier of Active Pharmaceutical Ingredients (API) and Formulated Products to the pharmaceutical industry. We have significant experience in contract manufacturing and are the partner of choice to several of the top ten global pharmaceutical leaders, emerging life science companies and leading generic manufacturers. Our Values Together with our key business partners we achieve outstanding results. Our company values are embedded in everything we do. • We are proud and passionate about Aesica, what we do and how we do it • We will understand our customers’ needs and we will always deliver on promises • We will be good corporate citizens in support of all our stakeholders • We will create an enjoyable working environment in which success is recognised, rewarded and celebrated • Every individual understands how their performance drives the success of the business.
Formulation Development SpecialistsWith a keen understanding of early stage development and clinical trial requirements, Aesica guides their customers through the processes of new medicine and material development for Phase 1 and Phase 2 clinical trials. They understand that their customers also need to maximise their budget effectiveness by minimising the amount of experimentation without sacrificing quality levels.Typical do…
